Education

The Pediatric Hematology/Oncology Fellowship is a world-renowned program with a long history of training leaders in the field. Our program offers a broad educational experience across the full spectrum of pediatric hematology, oncology and stem cell transplantation, with abundant opportunities for specialized focus. We’ve designed the program to be flexible and accommodate the goals and interests of each trainee, even as they change over the course of training.   

About the Program

Our program consists of two tracks through the UCSF Benioff Children’s Hospital locations in San Francisco and Oakland. Prospective fellows can apply to one or both of the San Francisco or Oakland tracks and rank them according to their preference. The track determines the location of their continuity clinic, but fellows in both tracks will spend time working in both San Francisco and Oakland. All trainees have access to the strengths, resources and programs of both hospitals, providing exposure to the diversity of the Bay Area and UCSF’s patient population.  

San Francisco has a strong history in training laboratory-based physician-scientists and clinicians with expertise in molecular oncology, stem cell transplantation and developmental therapeutics. Oakland features a rich variety of clinical exposure and a global reputation in hematology, particularly in hemoglobinopathies. Both tracks provide comprehensive training with expert faculty and access to unique opportunities rooted in the history, culture and expertise of each hospital.  

Upon completion of the program, fellows are board-eligible and experienced at providing compassionate care to children with malignancies and diseases of the blood and blood-forming organs. As part of one of the world’s premier academic medical institutions, our program offers a solid foundation in hypothesis-based scholarly investigation and trains physician-scientists who strive for academic careers as clinical investigators or in basic or translational science.

How to Apply

Applications are processed through the Electronic Residency Application Service (ERAS). The application opens for fellowship positions in July. 

In ERAS, the two tracks (San Francisco and Oakland) can be found by selecting “the University of California, San Francisco, School of Medicine” and then “University of California (San Francisco) Program”: 

  • For UCSF Benioff Children’s Hospital San Francisco, select “Pediatric Hematology/Oncology-San Francisco” 

  • For UCSF Benioff Children’s Hospital Oakland, select “Pediatric Hematology/Oncology-Oakland” 

Applicants are encouraged to apply to both tracks. Only one interview day will be required.  

Requirements 

  • Completed 2-3 years of training in an accredited residency program.  

  • Board-eligible in pediatrics.  

Instructions 

To apply, please submit a completed ERAS online application along with the following documents via the ERA system:  

  1. At least three letters of reference, including one from the residency program director. 

  1. MSPE (Medical Student Performance Evaluation) from your medical school and a medical school transcript. 

  1. Curriculum Vitae. 

  1. A personal statement describing your career goals and reasons for pursuing training in pediatric hematology/oncology. 

  1. Parts 1, 2 and 3 of the USMLE. 

  1. If a graduate of a medical school outside the United States, Canada, or Puerto Rico, a valid ECFMG certificate or one that does not expire prior to the start of the fellowship and evidence of previous training in the United States.  

  1. If not a citizen of the United States or permanent resident, provide a copy of current, appropriate visa.  

For questions regarding the application process or program, please e-mail Program Coordinator Karen Tan and Fellowship Director Arun Rangaswami

Curriculum

The first year of fellowship is nearly all clinical work, with two weeks of protected time to meet with potential research mentors and solidify research plans for the upcoming two years. Years two and three consist of 80+% protected time for trainees to pursue their interests in clinical specialties, basic science, translational science, medical education or any other avenue within the field.  

Clinical Schedule  

The first year of fellowship is nearly 100% clinical, with fellows spending time at both UCSF Benioff Children’s Hospital locations in San Francisco and Oakland. The track that the fellow is assigned to (San Francisco or Oakland) determines the location of their primary clinic and the specifics of their clinical rotation.   

During the first year of fellowship, trainees complete their clinical rotations and acquire a large panel of primary patients that they stay with throughout their time at the continuation clinic. First-year fellows receive 4 weeks of vacation and spend 8 weeks at their non-primary Benioff Children’s Hospital.    

San Francisco Schedule
Rotation Weeks Total Weeks
Hematology Inpatient/Consults 8 32
Oncology Inpatient/Consults 10
BMT Inpatient 8
Hematology/Oncology Inpatient/consults* 4
BMT/High Acuity Oncology inpatient* 2
Hematology Outpatient* 4 8
BMT Outpatient 2
Neuro-Oncology 2
Hematopathology/Blood Bank 2 8
Palliative Care 2
Radiation Oncology 1
Molecular Pathology 1
Research Planning 2
Vacation 4 4

* Rotations occur at Benioff Children's Hospital Oakland

Oakland Schedule
Rotation Weeks Total Weeks
Oncology Inpatient/Consults* 4 32
BMT Inpatient* 6
Hematology/Oncology Inpatient/Consults 16
BMT /High Acuity Oncology inpatient 6
Hematology/ Outpatient Clinics 6 8
Neuro-Oncology/BMT outpatient clinics 2
Hematopathology/Blood Bank* 2 8
Palliative Care 2
Radiation Oncology* 1
Molecular Pathology* 1
Research Planning 1
Vacation 4 4

* Rotations occur at Benioff Children's Hospital San Francisco 

Research Opportunities  

All research opportunities are available to fellows in both tracks, reducing barriers between trainees and their interests. Trainees can leverage the history and expertise of both UCSF Benioff Children’s Hospitals to create an individualized experience based on their interests.

All fellows are expected to complete a quality improvement (QI) project and have opportunities to publish and present other clinical projects. The program provides robust support with identifying and securing funding and mentorship opportunities based on a fellow’s background and research interests, including an NCI-funded T32 program that supports four fellows a year in either basic or clinical research.

The Innovative Genomics Institute, led by Nobel-prize winner and UCSF faculty Dr. Jennifer Doudna, is located close to the Oakland campus and can provide mentorship and funding for genomic engineering projects. Cell and gene therapy projects can receive support via training grants from the California Institute of Regenerative Medicine or the UCSF Alpha Clinic.

The Chan Zuckerberg Biohub Physician-Scientist Fellowship Program is available to trainees without a PhD background that are interested in pursuing a career as a physician-scientist. It provides weekly seminars, collaboration opportunities, and funding of 50% of the recipient’s salary for 2-3 years. 

Fellows in our program have a demonstrated extraordinary success at obtaining early career grant funding as a bridge to K-level awards in the years following completion of fellowship. Other commonly secured grants include St. Baldrick’s Foundation Fellowship Awards, Alex’s Lemonade Stand Young Investigator Grants, Hyundai Hope on Wheels Young Investigator Awards, American Society of Hematology Research Training Awards for Fellows, Damon Runyon Cancer Research Foundation Physician-Scientist Training Awards and the Department of Defense Peer Reviewed Cancer Research Program.

Educational Opportunities 

Fellows have access to graduate courses at UCSF and the popular Training in Clinical Research (TICR) program. This program offers trainees further education in clinical research methods. Individual courses, summer workshops, certificate programs and a full master’s in clinical and epidemiological research are all available. We typically have one fellow per year who completes their master’s degree during fellowship. 

The UCSF Helen Diller Family Comprehensive Cancer Center also offers education resources, including retreats, K grant-writing workshops, the Women in Leadership Development (WILD) program, and weekly research seminars. 

Program Leadership

Fellowship Director 

Associate Fellowship Directors 

Department of Pediatrics Division Chiefs 

Program Coordinators 

History of the Program

Formerly separate and independent, the Pediatric Hematology/Oncology Fellowship Programs at the two UCSF Benioff Children’s Hospitals, Oakland and San Francisco, have been combined into a single, stronger program. Both fellowships have been in existence for over 35 years and have a strong history in training leaders in basic, translational, and clinical research, medical education, and patient care across the field of pediatric hematology, oncology, and stem cell transplantation.   

Current Fellows

San Francisco

Matthew Decker

Matthew Decker 

Training Period: 2022-2025 
Medical School: UCSF (MD/PhD) 
Residency: UCSF 
Title of Research: Palmitoylation cycle inhibition in NRAS mutant cancers 

Benjamin Lerman

Benjamin Lerman 

Training Period: 2022-2025 
Medical School: Stanford University 
Residency: Children’s Hospital of Philadelphia 
Title of Research: Reconstructing clonal evolution and expansion in glioblastoma through longitudinal tumor-wide sampling

Russell Valle

Russell Valle 

Training Period: 2022-2025 
Medical School: Rutgers – Robert Wood Johnson Medical School  
Residency: New York Presbyterian-Morgan Stanley Children’s Hospital 
Title of Research: Partition Amplification with Capillary Electrophoresis (PACE): A Novel Technique for Molecular Minimal Residual Disease Testing for Fusion-Positive Acute Myeloid Leukemia 

Daniel Oder

Daniel Oder 

Training Period: 2023-2026 
Medical School: Ohio University Heritage College of Osteopathic Medicine 
Residency: Wright State University 
Title of Research: cfDNA and cfRNA for non-invasive determination of genome editing outcomes 

 Anya Platt

Anya Platt 

Training Period: 2023-2026 
Medical School: Sidney Kimmel Medical College at Thomas Jefferson University 
Residency: UCSF 
Title of Research: Outcomes in JMML patients undergoing haploidentical transplantation 

Emily Tomlinson

Emily Tomlinson 

Training Period: 2023-2026 
Medical School: University of Arizona College of Medicine - Tucson 
Residency: Medical College of Wisconsin 
Title of Research: Increased incidence of pre-leukemic hematopoietic clones in lower SES populations

Ana Falcon

 

Ana Fálcon 

Training Period: 2024-2027 
Medical School: Universidad Central de Venezuela Escuela de Medicina Jose Maria Vargas 
Residency: Tulane School of Medicine 
Title of Research: TBD

Cristina Perez

Cristina Perez 

Training Period: 2024-2027 
Medical School: Michigan State University College of Human Medicine 
Residency: UCSF Benioff Children's Hospital, Oakland 
Title of Research: TBD

Helen Tian

Helen Tian 

Training Period: 2024-2027 
Medical School: University of Massachusetts T.H. Chan School of Medicine 
Residency: Children's Hospital at Montefiore 
Title of Research: TBD

Oakland

Deborah Gho

Deborah Gho

Training Period: 2022-2025 
Medical School: Western University of Health Sciences  
Residency: Kaiser Permanente Los Angeles Medical Center 
Title of Research: Phase Ia/1b trial evaluating Idasanutlin in combination with chemotherapy or venetoclax in the treatment of pediatric patients with relapsed/refractory neuroblastoma.

Ophelia Tran

Ophelia Tran 

Training Period: 2022-2025 
Medical School: St. George’s University School of Medicine  
Residency: TTUHSC El Paso Paul Foster School of Medicine  
Title of Research: Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma: A Study of Patients Treated at UCSF Oakland between 2014 and 2023

Pallavi Agarwal 

Pallavi Agarwal 

Training Period: 2023-2026 
Medical School: Madurai Medical College 
Residency: University of Florida, Pensacola 
Title of Research: Clonal pathobiology associated with monosomy 7 hematopoiesis 

Krystle Frazier

Krystle Frazier 

Training Period: 2023-2026 
Medical School: University of California, Los Angeles David Geffen School of Medicine 
Residency: Harbor-UCLA Medical Center 
Title of Research: Using genetic modifiers and clinical phenotypes to predict renal dysfunction in patients with sickle cell disease 

 

Edward He

Edward He 

Training Period: 2024-2027 
Medical School: University of Central Florida College of Medicine 
Residency: University of Miami 
Title of Research: TBD

Taylor Pearl

Taylor Pearl 

Training Period: 2024-2027 
Medical School: Ohio State University College of Medicine 
Residency: Memorial Health/Children's Hospital of Savannah 
Title of Research: TBD

Resources and Links